Executive Summary SAGE October 2017, Pneumococcal ...

1 Executive Summary SAGE October 2017 , Pneumococcal Conjugate Vaccine Session Introduction Currently, WHO has recommended the use of either a 10-valent or 13-valent Pneumococcal conjugate vaccine (PCV10 and PCV13, respectively), for all infants worldwide. For routine immunization, WHO has recommended that PCV can be administered using either a 2p+1 or 3p+0 schedule, though 3p+1 schedules are also used in some countries[1]. A total of 141 countries have introduced PCV into their national immunization program, and 7 out of the 10 countries with the highest Pneumococcal disease burden have recently introduced the vaccine[2]. Since the introduction of the first PCV (PCV7) in 2000, global reductions in Pneumococcal disease burden in children under 5 years of age have been observed.

1 . Executive Summary SAGE October 2017, Pneumococcal Conjugate Vaccine Session . 1.0 Introduction Currently, WHO has recommended the use of either a 10-valent or 13-valent pneumococcal

Loading..

Tags:

  2017, October, October 2017

Information

Related search queries